Friday, April 30, 2021 3:06:34 PM
Is the exercise of warrants by insiders exempt from the rule that they cannot buy securities when in possession of material nonpublic information? If not until release of the P3 results these lockups were superfluous. So is the Powers 61 day lockup. The only legal effect until results release is that (she claims) she is not a beneficial owner of the shares associated with her warrants and options. Assume she knows results will not be released within 61 days. Then her purpose must be to avoid the legal status of beneficial owner of a certain percentage of her shares (or shares she could own by exercise of warrants or options).
Why would that be important to her? It would not insulate her from a shareholder derivative suit. Also, what consideration did she receive for her promise? If the answer is none, her agreement, or promise, is legally unenforceable. She does seem eager to avoid being treated as the beneficial owner of some threshold amount. Who is being reassured and concerning what?
Assuming she already was prohibited from purchasing shares through the exercise of warrants she is telling shareholders and the public that she promises (enforceably or otherwise), that she and their lawyer will not sell out to BP, except on 61 days notice. Even with the exercise of their warrants they could not transfer control to BP. Is this intended as assurance, or incentive, to other large shareholders not to combine to do so? Or small shareholders, in a tender offer? Are there insiders plus large warrant holders who control a majority of the common?
I understand there are poison pills and provisions to prevent change of control, but they can be held unenforceable, especially in companies where officers exercise effective control. We are all in the dark here. Just something else to speculate about.
Why would that be important to her? It would not insulate her from a shareholder derivative suit. Also, what consideration did she receive for her promise? If the answer is none, her agreement, or promise, is legally unenforceable. She does seem eager to avoid being treated as the beneficial owner of some threshold amount. Who is being reassured and concerning what?
Assuming she already was prohibited from purchasing shares through the exercise of warrants she is telling shareholders and the public that she promises (enforceably or otherwise), that she and their lawyer will not sell out to BP, except on 61 days notice. Even with the exercise of their warrants they could not transfer control to BP. Is this intended as assurance, or incentive, to other large shareholders not to combine to do so? Or small shareholders, in a tender offer? Are there insiders plus large warrant holders who control a majority of the common?
I understand there are poison pills and provisions to prevent change of control, but they can be held unenforceable, especially in companies where officers exercise effective control. We are all in the dark here. Just something else to speculate about.
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
